Cargando…

The Peripheral Blood Transcriptome Is Correlated With PET Measures of Lung Inflammation During Successful Tuberculosis Treatment

Pulmonary tuberculosis (PTB) is characterized by lung granulomas, inflammation and tissue destruction. Here we used within-subject peripheral blood gene expression over time to correlate with the within-subject lung metabolic activity, as measured by positron emission tomography (PET) to identify bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Odia, Trust, Malherbe, Stephanus T., Meier, Stuart, Maasdorp, Elizna, Kleynhans, Léanie, du Plessis, Nelita, Loxton, Andre G., Zak, Daniel E., Thompson, Ethan, Duffy, Fergal J., Kuivaniemi, Helena, Ronacher, Katharina, Winter, Jill, Walzl, Gerhard, Tromp, Gerard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902901/ https://www.ncbi.nlm.nih.gov/pubmed/33643286 http://dx.doi.org/10.3389/fimmu.2020.596173

Ejemplares similares

The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis
por: du Plessis, Willem J., et al.
Publicado: (2016)

Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis
por: Meier, Stuart, et al.
Publicado: (2022)

Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis
por: Leukes, Vinzeigh N., et al.
Publicado: (2021)

Medroxyprogesterone Acetate Alters Mycobacterium Bovis BCG-Induced Cytokine Production in Peripheral Blood Mononuclear Cells of Contraceptive Users
por: Kleynhans, Léanie, et al.
Publicado: (2011)

Mycobacterium bovis BCG infection severely delays Trichuris muris expulsion and co-infection suppresses immune responsiveness to both pathogens
por: Nel, Hendrik J, et al.
Publicado: (2014)

Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response
por: Jacobs, Ruschca, et al.
Publicado: (2016)

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa
por: Hiemstra, Andriёtte M., et al.
Publicado: (2022)

Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa
por: Shaw, Jane Alexandra, et al.
Publicado: (2021)

Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy
por: Beltran, Caroline G. G., et al.
Publicado: (2020)

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes
por: Ronacher, Katharina, et al.
Publicado: (2019)

Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
por: Malherbe, Stephanus T., et al.
Publicado: (2020)

Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure
por: Malherbe, Stephanus T., et al.
Publicado: (2016)

B‐cells with a FasL expressing regulatory phenotype are induced following successful anti‐tuberculosis treatment
por: van Rensburg, Ilana C., et al.
Publicado: (2016)

Host blood RNA signatures predict the outcome of tuberculosis treatment
por: Thompson, Ethan G., et al.
Publicado: (2017)

Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid Profile
por: Vrieling, Frank, et al.
Publicado: (2018)

Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients
por: Leukes, Vinzeigh N., et al.
Publicado: (2022)

Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology
por: Munansangu, Brian S. M., et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)

Interplay Between the Immune and Endocrine Systems in the Lung: Implications for TB Susceptibility
por: Webber, Tariq, et al.
Publicado: (2022)

Establishment of a Patient-Derived, Magnetic Levitation-Based, Three-Dimensional Spheroid Granuloma Model for Human Tuberculosis
por: Kotze, Leigh A., et al.
Publicado: (2021)

Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response
por: Jacobs, Ruschca, et al.
Publicado: (2016)

Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis
por: Eckold, Clare, et al.
Publicado: (2020)

A semi-automatic technique to quantify complex tuberculous lung lesions on (18)F-fluorodeoxyglucose positron emission tomography/computerised tomography images
por: Malherbe, Stephanus T., et al.
Publicado: (2018)

Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
por: du Plessis, Nelita, et al.
Publicado: (2018)

Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases
por: Kotze, Leigh Ann, et al.
Publicado: (2022)

119. Prospective Validation of a 3-Gene Signature for Tuberculosis Diagnosis, Predicting Progression and Evaluating Treatment Response
por: Warsinske, Hayley, et al.
Publicado: (2018)

Changes in Host Immune–Endocrine Relationships during Tuberculosis Treatment in Patients with Cured and Failed Treatment Outcomes
por: Kleynhans, Léanie, et al.
Publicado: (2017)

Phenotypic analysis of peripheral B cell populations during Mycobacterium tuberculosis infection and disease
por: du Plessis, Willem J., et al.
Publicado: (2016)

The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
por: Eribo, Osagie A., et al.
Publicado: (2019)

Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells
por: John, Vini, et al.
Publicado: (2019)

Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA
por: van Rensburg, Ilana C., et al.
Publicado: (2016)

An Archetypical Model for Engrafting Bacteroides fragilis into Conventional Mice Following Reproducible Antibiotic Conditioning of the Gut Microbiota
por: Eribo, Osagie A., et al.
Publicado: (2023)

Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment
por: van Doorn, Cassandra L.R., et al.
Publicado: (2022)

121. Improving Predictive Value of Phase 2a TB Drug Development Models Through PET/CT Imaging (NexGen EBA)
por: Xie, Yingda, et al.
Publicado: (2018)

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity
por: Eckold, Clare, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_00sb7hecef8bnhgt6m61ek2e8p